| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
42,312 |
39,057 |
$2.57M |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
9,635 |
9,091 |
$771K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
7,079 |
6,594 |
$288K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
7,411 |
6,961 |
$208K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
3,908 |
3,733 |
$206K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,308 |
3,159 |
$139K |
| 99215 |
Prolong outpt/office vis |
853 |
829 |
$73K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,684 |
2,590 |
$33K |
| 87400 |
|
1,116 |
545 |
$11K |
| 87428 |
|
302 |
292 |
$9K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
66 |
48 |
$7K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
265 |
195 |
$4K |
| 81002 |
|
1,237 |
1,197 |
$3K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
53 |
44 |
$1K |
| 81025 |
|
95 |
93 |
$616.26 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
19 |
13 |
$272.65 |
| 94760 |
|
1,084 |
1,024 |
$1.44 |
| 99000 |
|
1,353 |
1,309 |
$0.00 |